Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration01:25

Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration

Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
Hemoglobin01:24

Hemoglobin

Hemoglobin is a globular protein made up of four subunits. Two of these subunits are alpha chains, and the other two are beta chains. Each subunit contains a molecule of heme, which has an iron atom and can bind to oxygen. When an oxygen molecule binds to one heme group, it changes the shape of hemoglobin, making it easier for the other heme groups to bind oxygen as well.
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
Drug Distribution: Plasma Protein Binding01:29

Drug Distribution: Plasma Protein Binding

Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
Protein Buffers in Blood Plasma and Cells01:20

Protein Buffers in Blood Plasma and Cells

The human body utilizes protein buffer systems to maintain a stable pH. These systems capitalize on the dual role of amino acids, which can act as acids or bases by accepting or releasing hydrogen ions in response to pH changes. Protein buffer systems are particularly significant in the extracellular fluid (ECF) and intracellular fluid (ICF) of active cells, where structural and functional proteins provide substantial buffering capacity.
Certain amino acids can exist in a zwitterion state at a...
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation01:22

Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation

Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Enhanced Elimination of Poison01:26

Enhanced Elimination of Poison

Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development and preclinical evaluation of an asialoglycoprotein receptor 1-targeted antibody-drug conjugate in hepatic inflammation.

International journal of biological macromolecules·2026
Same author

Evaluation of stored whole blood cellular components treated with bactericidal peptides at a higher concentration than required to assess the peptide compatibility with product quality.

Blood transfusion = Trasfusione del sangue·2026
Same author

A novel transdermal curcumin gel shows potential in improving cardiac bioenergetic functions in Berkeley sickle cell mice.

Blood vessels, thrombosis & hemostasis·2026
Same author

Digital Microfluidics-Driven Cell-Free Protein Synthesis Platform Reveals Expression and Stability Determinants for Phytoglobins and Cysteine-to-Alanine Substituted Variants.

Antioxidants (Basel, Switzerland)·2025
Same author

CD163 Expression Protects Against Early Hepatic Steatosis in Western Diet-Fed Male Mice.

Gastro hep advances·2025
Same author

Class 1 Sugar Beet Phytoglobin Shows Strong Affinity to Glyceraldehyde-3-Phosphate Dehydrogenase and DNA In Vitro.

International journal of molecular sciences·2025

Related Experiment Video

Updated: May 17, 2026

Measurement of Heme Synthesis Levels in Mammalian Cells
09:43

Measurement of Heme Synthesis Levels in Mammalian Cells

Published on: July 9, 2015

Haptoglobin: the hemoglobin detoxifier in plasma.

Abdu I Alayash, Christian Brix Folsted Andersen, Søren Kragh Moestrup

    Trends in Biotechnology
    |November 13, 2012
    PubMed
    Summary

    Free hemoglobin (Hb) causes oxidative toxicity and inflammation. Haptoglobin (Hp) protein binding neutralizes Hb's damaging radicals, offering potential therapeutic benefits for various clinical settings.

    Area of Science:

    • Biochemistry
    • Molecular Biology
    • Immunology

    Background:

    • Free hemoglobin (Hb) in circulation is increasingly recognized for its oxidative toxicity, contributing to inflammation and transfusion complications.
    • Haptoglobin (Hp), a plasma protein, plays a crucial role in protecting against Hb-induced damage.
    • Recent structural resolution of the Hb-Hp complex provides a molecular basis for their interaction.

    Discussion:

    • Oxidative stress conditions exacerbate the damaging effects of free Hb.
    • Hb-Hp complex formation effectively harnesses and neutralizes Hb-derived radicals.
    • Understanding this interaction is key to mitigating Hb-related pathologies.

    Key Insights:

    • The crystal structure of the Hb-Hp complex elucidates the functional and structural interplay between Hb and Hp.

    More Related Videos

    In vivo Liver Endocytosis Followed by Purification of Liver Cells by Liver Perfusion
    12:35

    In vivo Liver Endocytosis Followed by Purification of Liver Cells by Liver Perfusion

    Published on: November 10, 2011

    A Rapid and Chemical-free Hemoglobin Assay with Photothermal Angular Light Scattering
    05:18

    A Rapid and Chemical-free Hemoglobin Assay with Photothermal Angular Light Scattering

    Published on: December 7, 2016

    Related Experiment Videos

    Last Updated: May 17, 2026

    Measurement of Heme Synthesis Levels in Mammalian Cells
    09:43

    Measurement of Heme Synthesis Levels in Mammalian Cells

    Published on: July 9, 2015

    In vivo Liver Endocytosis Followed by Purification of Liver Cells by Liver Perfusion
    12:35

    In vivo Liver Endocytosis Followed by Purification of Liver Cells by Liver Perfusion

    Published on: November 10, 2011

    A Rapid and Chemical-free Hemoglobin Assay with Photothermal Angular Light Scattering
    05:18

    A Rapid and Chemical-free Hemoglobin Assay with Photothermal Angular Light Scattering

    Published on: December 7, 2016

  • Hp binding inactivates cell-free Hb, preventing oxidative damage.
  • This interaction demonstrates a critical protective mechanism against circulating Hb toxicity.
  • Outlook:

    • Haptoglobin therapy holds promise for inactivating and clearing free Hb in various clinical scenarios.
    • Further research into Hb-Hp interactions could lead to novel treatments for inflammatory and transfusion-related complications.
    • Targeting Hb-Hp dynamics may offer new therapeutic strategies for conditions involving oxidative stress.